Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
increased risk of pancreatic cancer
|
6 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Multiple Myeloma
|
865 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Nevus Sebaceus of Jadassohn
|
7 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Primary low grade serous adenocarcinoma of ovary
|
1 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 0 | ||||||||
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER
|
14 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Adult Glioblastoma
|
98 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.010 | 1 | 2007 | 2007 | ||||||
Childhood Glioblastoma
|
98 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.010 | 1 | 2007 | 2007 | ||||||
Glioblastoma
|
281 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.010 | 1 | 2007 | 2007 | ||||||
Glioblastoma Multiforme
|
186 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.010 | 1 | 2007 | 2007 | ||||||
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
23 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.010 | 1 | 2016 | 2016 | ||||||
Tumor Progression
|
72 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 0.800 | 5 | 2011 | 2017 | |||||
Carcinogenesis
|
355 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.857 | 14 | 2003 | 2016 | |||||
Lung Neoplasms
|
39 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.080 | 0.875 | 8 | 2008 | 2016 | |||||
Malignant neoplasm of lung
|
1142 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||
Colorectal Carcinoma
|
1962 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.923 | 13 | 1999 | 2020 | |||||
Carcinoma of lung
|
1204 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.933 | 15 | 2010 | 2019 | |||||
Neoplasms
|
1644 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.970 | 67 | 1999 | 2020 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.790 | 1.000 | 26 | 2002 | 2019 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 13 | 2008 | 2019 | |||||
Colorectal Neoplasms
|
609 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.700 | 1.000 | 12 | 2005 | 2014 | |||||
Primary malignant neoplasm
|
1374 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 11 | 2009 | 2019 | |||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
80 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2010 | 2018 | |||||
Juvenile Myelomonocytic Leukemia
|
70 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.820 | 1.000 | 10 | 2005 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2009 | 2019 |